梅特福林使用与新发糖尿病患者发生痴呆症之间的相关性:基于人口的研究
Kuang-Hua Huang1, Ya-Fang Tsai2, Chiachi Bonnie Lee1
1Department of Health Services Administration, China Medical University, Taichung 406040, Taiwan.
Journal of personalized medicine
|May 27, 2023
概括
在糖尿病患者中使用低强度甲福林可能会降低痴呆症风险. 较高的剂量和强度没有显示出保护作用,因此需要进一步研究甲胺和痴呆症机制.
科学领域:
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 关于甲福明对痴呆风险的影响,存在相互矛盾的证据.
- 糖尿病是一种已知的痴呆症风险因素.
- 了解DM患者的药物效应对于认知健康至关重要.
研究的目的:
- 调查新发糖尿病患者的甲福明使用与痴呆风险之间的关联.
- 分析甲福明剂量和强度对痴呆发病率的影响.
主要方法:
- 对新出现的DM患者 (2002-2013) 的回顾性队列研究.
- 根据甲福明使用 (是/否) 分类的患者.
- 在3年和5年的随访期间,通过累积定义的每日剂量 (cDDD) 和每月强度 (DDD/月) 评估的甲胺使用.
主要成果:
- 低累积的甲福明使用 (cDDD < 300) 与痴呆症风险降低有关 (OR = 0.92).
- 低强度甲胺使用 (<10和10-25 DDD/月) 显示出类似的保护作用 (OR = 0.92).
- 更高的累积剂量 (300-500,>500cDDD) 和更高的强度 (>25 DDD/月) 没有显示出与痴呆风险的保护性关联.
结论:
- 低强度甲福明的使用可能与糖尿病患者痴呆风险降低有关.
- 较高的甲福林剂量或强度似乎没有提供对痴呆症的保护性益处.
- 需要进行进一步的前性临床试验,以阐明甲福尔剂量和痴呆风险背后的机制.
相关概念视频
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
241
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
241
01:30Dementia
144
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
144
01:22Diabetes Mellitus: Type 2 and Gestational
2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
01:19Psychoneuroimmunology: Diabetes and Cancer
50
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
50
01:23Dipeptidyl Peptidase 4 Inhibitors
216
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
216
01:15Diabetes: Symptoms, Diagnosis, and Complications
606
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
606